EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Structural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy

Grant J Logan, Mario Mietzsch, Neeta Khandekar, Arlene D'Silva, Daniel Anderson, Mawj Mandwie, Jane Hsi, Austin R Nelson, Paul Chipman, Jennifer Jackson, Peter Schofield, Daniel Christ und 5 weitere

Molecular Therapy · 2023

DOI: 10.1016/j.ymthe.2023.03.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2023. Verfasst von Grant J Logan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Gene Therapy Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney and Sydney Children's Hos…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Capsid. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Success in the treatment of infants with spinal muscular atrophy (SMA) underscores the potential of vectors based on adeno-associated virus (AAV). However, a major obstacle to the full realization of this potential is pre-existing natural and therapy-induced anti-capsid humoral immunity. Structure-guided capsid engineering is one possible approach to surmounting this challenge but necessitates an understanding of capsid-antibody interactions at high molecular resolution. Currently, only mouse-derived monoclonal antibodies (mAbs) are available to structurally map these interactions, which presupposes that mouse and human-derived antibodies are functionally equivalent. In this study, we have characterized the polyclonal antibody responses of infants following AAV9-mediated gene therapy for SMA and recovered 35 anti-capsid mAbs from the abundance of switched-memory B (smB) cells present in these infants. For 21 of these mAbs, seven from each of three infants, we have undertaken functional and structural analysis measuring neutralization, affinities, and binding patterns by cryoelectron microscopy (cryo-EM). Four distinct patterns were observed akin to those reported for mouse-derived mAbs, but with early evidence of differing binding pattern preference and underlying molecular interactions. This is the first human and largest series of anti-capsid mAbs to have been comprehensively characterized and will prove to be powerful tools for basic discovery and applied purposes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalCapsidInfantHumansAnimalsMiceCryoelectron MicroscopyCapsid ProteinsDependovirusGenetic TherapyGenetic Vectors

Stichwörter der Autor:innen

Zolgensmaadeno-associated virus vectoraffinityanti-vector immunitycapsidcapsid structuremonoclonal antibodyneutralizationrecombinant AAVspinal muscular atrophy

Substanzen

Antibodies, MonoclonalCapsid Proteins

Autor:innen und Institutionen

  • Gene Therapy Research Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney and Sydney Children's Hospitals Network, Westmead, NSW, Australia.
  • Department of Biochemistry and Molecular Biology, Center for Structural Biology, McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA.
  • School of Women's and Children's Health, University of New South Wales Medicine, UNSW Sydney, Sydney, NSW, Australia.
  • Garvan Institute of Medical Research, UNSW Sydney, Faculty of Medicine, Darlinghurst, NSW, Australia.
  • Garvan Institute of Medical Research, UNSW Sydney, Faculty of Medicine, Darlinghurst, NSW, Australia; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, NSW, Australia.
  • Westmead Institute for Medical Research, Centre for Immunology and Allergy Research, Westmead, NSW, Australia.

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health
  • National Health and Medical Research Council
  • Rebecca L Cooper Medical Research Foundation

Zitieren

APA

Logan, G. J., Mietzsch, M., Khandekar, N., D'Silva, A., Anderson, D., Mandwie, M., Hsi, J., Nelson, A. R., Chipman, P., Jackson, J., Schofield, P., Christ, D., Goodnow, C. C., Reed, J. H., Farrar, M. A., McKenna, R., & Alexander, I. E. (2023). Structural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2023.03.032

Vancouver

Logan GJ, Mietzsch M, Khandekar N, D'Silva A, Anderson D, Mandwie M, et al. Structural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy. Molecular Therapy. 2023. doi:10.1016/j.ymthe.2023.03.032

BibTeX
@article{Logan2023,
  author = {Logan, Grant J and Mietzsch, Mario and Khandekar, Neeta and D'Silva, Arlene and Anderson, Daniel and Mandwie, Mawj and Hsi, Jane and Nelson, Austin R and Chipman, Paul and Jackson, Jennifer and Schofield, Peter and Christ, Daniel and Goodnow, Christopher C and Reed, Joanne H and Farrar, Michelle A and McKenna, Robert and Alexander, Ian E},
  title = {Structural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy},
  journal = {Molecular Therapy},
  year = {2023},
  doi = {10.1016/j.ymthe.2023.03.032}
}
Kostenlos starten →